NCT00165269

Mantle Irradiation for Hodgkin's Disease

Mantle Irradiation for Selected Hodgkin's Disease Patients With Stage IA-IIA Disease

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Dana-Farber Cancer Institute · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study it to evaluate the effectiveness of radiation therapy limited to above the diaphragm in patients with pathological stage IA-IIA Hodgkin's disease.

Detailed description

* Eligble patients will receive a course of radiation therapy directed to above the diaphragm only. * Patients would have bloodwork and chest x-rays performed 4 times per year for the first two years, 3 times per year for the third year, and 2 times per year for the fourth and fifth years. After five years, yearly check-ups are performed. * In addition to the above follow-up, patients will receive, once or twice a year for the first 5 years, an abdominal-pelvic CT scan and/or gallium scan.

Conditions

• Hodgkin's Disease

Interventions

Type	Name	Description
PROCEDURE	Mantle irradiation	Limited to above the diaphragm

Timeline

• Start date: 1992-05-01
• Primary completion: 2000-06-01
• Completion: 2008-02-01
• First posted: 2005-09-14
• Last updated: 2009-11-02

Locations

2 sites across 1 country: United States